PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

about

Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.

P2860

Q38698251-C64E1EBA-3C62-4FAE-AD2B-BB7D291ED5ED Q49888038-A35864C8-98AF-41E5-963C-7FA0F32B928C

P2860

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

Item

http://www.wikidata.org/entity/Q38732488

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

PROTOCADHERIN 7 Acts through S ...... RAS during Lung Tumorigenesis.

@en

type

Item

label

PROTOCADHERIN 7 Acts through S ...... RAS during Lung Tumorigenesis.

@en

prefLabel

PROTOCADHERIN 7 Acts through S ...... RAS during Lung Tumorigenesis.

@en

P1476

PROTOCADHERIN 7 Acts through S ...... RAS during Lung Tumorigenesis.

@en

P2093

Barrett L Updegraff

http://www.w3.org/2001/XMLSchema#string

Carmen Behrens

http://www.w3.org/2001/XMLSchema#string

Jaime Rodriguez-Canales

http://www.w3.org/2001/XMLSchema#string

Jill E Larsen

http://www.w3.org/2001/XMLSchema#string

John D Minna

http://www.w3.org/2001/XMLSchema#string

Kathryn A O'Donnell

http://www.w3.org/2001/XMLSchema#string

Luc Girard

http://www.w3.org/2001/XMLSchema#string

Michael Peyton

http://www.w3.org/2001/XMLSchema#string

Pamela Villalobos

http://www.w3.org/2001/XMLSchema#string

Tae Hyun Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A

The hippo signaling pathway in development and cancer

Genes that mediate breast cancer metastasis to the brain

PP2A: more than a reset switch to activate pRB proteins during the cell cycle and in response to signaling cues.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer

Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein

Comprehensive molecular profiling of lung adenocarcinoma.

Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia

P304

187-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-16-1267-T

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ignacio I Wistuba

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27821484

http://www.w3.org/2001/XMLSchema#string

P932

5410365

http://www.w3.org/2001/XMLSchema#string

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

about

P2860

P2860

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932